Description:

NCT00134810 The main purpose of this study is to determine which is the best dose of a drug known as Dysport to give when treating one's type of upper back pain. The study will also examine the side effects of this treatment and its overall effect on one's disorder.

Keywords:
Versions (2) ▾
  1. 12/11/13
  2. 5/20/15
Uploaded on:

May 20, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Upper Back Myofascial Pain Syndrome NCT00134810

Eligibility Upper Back Myofascial Pain Syndrome NCT00134810

Inclusion criteria
18 Years and older
No Healthy Volunteers
Moderate-severe pain in upper back
Myofascial pain syndrome for more than 6 months
Active trigger points in upper back
Exclusion criteria
Fibromyalgia and other non-myofascial pain conditions of upper back
Duration of myofascial pain syndrome no longer than 24 months
Steroid injections during previous 3 months
Anaesthetic injection at trigger points during previous 1 month